Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue

详细信息    查看全文

• 作者：Marie-Madeleine Dolmans ; M.D. ; Ph.D.^a ; ^{marie-madeleine.dolmans@uclouvain.be} ; Valé ; rie Luyckx ; M.D.^a ; Jacques Donnez ; M.D. ; Ph.D.^b ; Claus Yding Andersen ; D.M.Sc.^c ; Tine Greve ; M.D.^c
• 关键词：Ovarian tissue cryopreservation ; ovarian tissue transplantation ; cancer ; risk ; malignant cells
• 刊名：Fertility and Sterility
• 出版年：2013
• 出版时间：May, 2013
• 年：2013
• 卷：99
• 期：6
• 页码：1514-1522
• 全文大小：725 K

文摘

Ovarian tissue cryopreservation and transplantation is a real option to preserve and restore fertility in young cancer patients. However, there is a concern regarding the possible presence of malignant cells in the ovarian tissue, which could lead to recurrence of the primary disease after reimplantation. A review of the existing literature was done to evaluate the risk of transplanting malignant cells in case of the main malignant indications for ovarian tissue cryopreservation. For ovarian tissue from patients with hematologic malignancies, it is of paramount importance to identify minimal residual disease before ovarian tissue transplantation. Indeed, these pathologies, reviewed here in detail, are considered to be most at risk of ovarian metastasis.